Colorectal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Malignant neoplasm of gallbladder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Gallbladder Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Stage 0 Gallbladder Cancer AJCC v8
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Stage IIA Gallbladder Cancer AJCC v8
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Stage IIB Gallbladder Cancer AJCC v8
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Stage III Gallbladder Cancer AJCC v8
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Stage IV Gallbladder Cancer AJCC v8
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin-like protein-2 (SLP-2) gene belongs to the stomatin supergene family, and previous studies have revealed up-regulated SLP-2 expression in gallbladder cancer, lung cancer, and esophageal cancer, while the role of SLP-2 in colorectal cancer (CRC) remains unclear and needs further investigation.
|
30389319 |
2019 |
Pseudohyperkalemia Cardiff
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The cryohydrocytosis phenotype, including South-east Asian Ovalocytosis, results from mutations in <i>SLC4A1</i>, and the very rare condition, stomatin-deficient cryohydrocytosis, is caused by mutations in <i>SLC2A1</i>.
|
29713289 |
2018 |
Osteoporosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Moreover, in stomatin transgenic mice, increased cell fusion leading to enhanced bone resorption and subsequent osteoporosis were observed.
|
27663861 |
2017 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Stomatin-like protein 2 (SLP-2), a member of the stomatin protein family, has emerged as a potential molecular hallmark of tumor progression in several human malignancies.
|
26750533 |
2016 |
Tumor Progression
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Stomatin-like protein 2 (SLP-2), a member of the stomatin protein family, has emerged as a potential molecular hallmark of tumor progression in several human malignancies.
|
26750533 |
2016 |
Tumor Progression
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma.
|
25695396 |
2015 |
Malignant tumor of cervix
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate the prognostic role of stomatin-like protein 2 (STOML2) in cervical cancer.
|
25973071 |
2015 |
Esophageal carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma.
|
25695396 |
2015 |
Cervix carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate the prognostic role of stomatin-like protein 2 (STOML2) in cervical cancer.
|
25973071 |
2015 |
cervical cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate the prognostic role of stomatin-like protein 2 (STOML2) in cervical cancer.
|
25973071 |
2015 |
Malignant Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Several studies have indicated that overexpression of stomatin-like protein 2 (SLP-2) has been identified in several types of cancer.
|
23918306 |
2014 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Stomatin-like protein 2 (SLP-2) is a novel member of the stomatin superfamily and is found in several types of human tumors.
|
24190591 |
2014 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Several studies have indicated that overexpression of stomatin-like protein 2 (SLP-2) has been identified in several types of cancer.
|
23918306 |
2014 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our data demonstrate for the first time that expression of stomatin, a poorly studied microdomain-forming protein, significantly changes in human tumors, thus pointing to its importance in the progression of NSCLC.
|
24533441 |
2014 |
Ichthyosis, X-Linked
|
0.010 |
Biomarker
|
disease |
BEFREE |
At the present time, there is a lack of data about the involvement of flotillins and stomatin in the development of non-small cell lung cancer (NSCLC) and soft tissue sarcomas (STS).
|
24533441 |
2014 |
Gastric Adenocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of stomatin-like protein 2 (STOML2) predicts decreased survival in gastric adenocarcinoma: a retrospective study.
|
24258357 |
2014 |
Secondary malignant neoplasm of lymph node
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Stomatin protein expression was down-regulated in 80% of NSCLC samples and this decrease significantly associated with presence of lymph node metastases.
|
24533441 |
2014 |
Sarcoma
|
0.010 |
Biomarker
|
group |
BEFREE |
At the present time, there is a lack of data about the involvement of flotillins and stomatin in the development of non-small cell lung cancer (NSCLC) and soft tissue sarcomas (STS).
|
24533441 |
2014 |